Artificial Intelligence in Diabetes Management Market to Grow with a CAGR of 12.15% through 2028
AI's ability to provide personalized treatment plans,
continuous monitoring, and predictive analytics are expected to drive the
Global Artificial Intelligence in Diabetes Management Market growth in the
forecast period, 2024-2028.
According to TechSci Research report, “Artificial
Intelligence in Diabetes Management Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Artificial
Intelligence in Diabetes Management Market stood at USD 550.41 million in 2022
and is anticipated to grow with a CAGR of 12.15% in the forecast period,
2024-2028. This can be attributed to data integration. AI facilitates the
integration of data from various sources, including wearable devices,
electronic health records, and mobile apps. This holistic view of a patient's
health enables healthcare professionals to make more informed decisions about
diabetes management. It also streamlines the exchange of information among
different stakeholders in the healthcare ecosystem.
Moreover, as AI becomes more deeply integrated into
diabetes care, ethical considerations will gain prominence. There will be a
focus on addressing bias in algorithms, ensuring transparency in AI
decision-making, and promoting fairness in healthcare access. Ethical AI
principles will guide the development and deployment of AI-driven diabetes
management solutions.
The Global Artificial Intelligence in Diabetes
Management Market refers to the use of artificial intelligence (AI)
technologies in the management and treatment of diabetes. AI has been
increasingly employed in healthcare to enhance the accuracy and efficiency of
diagnosis, monitoring, and treatment of various diseases, including diabetes.
The Global Artificial Intelligence in Diabetes
Management Market is segmented into device, technique, regional distribution,
and company.
Based on its device, Glucose monitoring devices are
poised to capture a substantial market share in the Global Artificial
Intelligence in Diabetes Management Market during the forecast period for
several compelling reasons. Firstly, the rising prevalence of diabetes worldwide
has spurred the demand for advanced tools to manage the condition effectively.
Secondly, the integration of artificial intelligence (AI) into glucose
monitoring devices has enhanced their accuracy and efficiency, enabling
real-time data analysis and personalized treatment recommendations. Moreover,
the growing adoption of wearable and IoT-based healthcare technologies has made
continuous glucose monitoring more accessible and convenient for patients. As a
result, these devices are anticipated to play a pivotal role in the evolution
of diabetes management, making them a prominent player in the market's growth
trajectory.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Artificial Intelligence in Diabetes Management Market.”
Based on technique, Intelligent data analysis is
poised to claim a substantial market share in the Global Artificial
Intelligence in Diabetes Management Market during the forecast period for
several compelling reasons. Firstly, the sheer volume of data generated by
diabetes patients, including glucose levels, lifestyle data, and medical
history, necessitates advanced analytical tools to extract meaningful insights.
Secondly, the application of artificial intelligence in data analysis enables
healthcare professionals to identify patterns, predict glucose fluctuations,
and customize treatment plans more effectively, ultimately improving patient
outcomes. Furthermore, the continuous advancements in AI algorithms and machine
learning techniques are making data analysis more accurate and efficient,
driving the adoption of intelligent data analysis solutions in diabetes
management. As the demand for precision medicine and personalized care grows,
intelligent data analysis is expected to play a pivotal role in shaping the
future of diabetes management, solidifying its prominence in the market.
Major companies operating in Global Artificial
Intelligence in Diabetes Management Market are:
- Vodafone Group PLC
- Apple Inc
- Google Inc
- International Business Machines
Corporation (IBM)
- Glooko Inc
- Tidepool Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The future of diabetes management is exciting, with
AI poised to revolutionize the way we prevent, diagnose, and treat this chronic
condition. From predictive analytics and personalized treatment plans to CGM
advancements and telemedicine expansion, these upcoming trends promise to
enhance the quality of life for individuals with diabetes. As AI-driven
solutions continue to evolve, they hold the potential to not only improve
patient outcomes but also to alleviate the global burden of diabetes on
healthcare systems and society as a whole,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“Artificial Intelligence in Diabetes Management Market
By
Device (Diagnostic Devices, Glucose Monitoring
Devices, Insulin Delivery Devices), By Technique (Case-Based Reasoning,
Intelligent Data Analysis), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Artificial Intelligence in Diabetes
Management Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Artificial
Intelligence in Diabetes Management Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com